Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by streptococcus pneumoniae

American Journal of Respiratory Cell and Molecular Biology

Volumn 46, Issue 2, 2012, Pages 180-187

  Wilkosz, Sylwia ^a   Edwards, Lindsey A ^a   Bielsa, Silvia ^a,b   Hyams, Catherine ^a   Taylor, Abigail ^a   Davies, Robert J O ^c   Laurent, Geoffrey J ^a   Chambers, Rachel C ^a   Brown, Jeremy S ^a   Lee, Y C Gary ^a,b,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LLEIDA   (Spain)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Animal models; Empyema; Mesothelial cells; Streptoccocus pneumoniae; Translocation

Indexed keywords

INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BACTERIAL CLEARANCE; BACTERIAL STRAIN; CELL INFILTRATION; COLONY FORMING UNIT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CULTURE TECHNIQUE; DISEASE ASSOCIATION; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MESOTHELIUM; MOUSE; NEUTROPHILIA; NONHUMAN; PATHOGENESIS; PLEURA CAVITY; PLEURA EMPYEMA; PLEURA FLUID; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; DISEASE MODELS, ANIMAL; EMPYEMA; LUNG DISEASES; MICE; PLEURA; PLEURAL DISEASES; STREPTOCOCCUS PNEUMONIAE;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84863012454     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0182OC     Document Type: Article

References (32)

1. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax 2003;58(Suppl 2):ii18-8.
2. Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg 2007;133:346-351.
3. Roxburgh CS, Youngson GG, Townend JA, Turner SW. Trends in pneumonia and empyema in Scottish children in the past 25 years. Arch Dis Child 2008;93:316-318. (Pubitemid 352025830)
4. Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008;27:1030-1032.
5. Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J 2008;15:85-89. (Pubitemid 351676396)
6. Stathopoulos GT, Lee YCG. Animal model in pleural diseases. In: Textbook of pleural diseases, 2nd ed. London: Arnold Press. pp. 169-186, 2012.
7. Zhu Z, Hawthorne ML, Guo Y, Drake W, Bilaceroglu S, Misra HL, Light RW. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006;129:1577-1583. (Pubitemid 43894989)
8. Sasse SA, Jadus MR, Kukes GD. Pleural fluid transforming growth factor-beta1 correlates with pleural fibrosis in experimental empyema. Am J Respir Crit Care Med 2003;168:700-705. (Pubitemid 37175972)
9. Sasse S, Nguyen TK, Mulligan M, Wang NS, Mahutte CK, Light RW. The effects of early chest tube placement on empyema resolution. Chest 1997;111:1679-1683. (Pubitemid 27260102)
10. Mohammed KA, Nasreen N, Hardwick J, Logie CS, Patterson CE, Antony VB. Bacterial induction of pleural mesothelial monolayer barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001;281:L119-L125.
11. Nasreen N, Mohammed KA, Hardwick J, Van Horn RD, Sanders KL, Doerschuk CM, Hott JW, Antony VB. Polar production of interleukin-8 by mesothelial cells promotes the transmesothelial migration of neutrophils: role of intercellular adhesion molecule-1. J Infect Dis 2001;183:1638-1645. (Pubitemid 32466702)
12. Nasreen N, Mohammed KA, Sanders KL, Hardwick J, Van Horn RD, Sharma RK, Kilani M, Antony VB. Pleural mesothelial cells modulate polymorphonuclear leukocyte apoptosis in empyema. J Clin Immunol 2003;23:1-10. (Pubitemid 36207972)
13. Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006;174:817-823. (Pubitemid 44511664)
14. Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, Walport MJ, Botto M. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 2002;99:16969-16974. (Pubitemid 36034082)
15. Yuste J, Botto M, Bottoms SE, Brown JS. Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog 2007;3:1208-1219. (Pubitemid 47510274)
16. Yuste J, Botto M, Paton JC, Holden DW, Brown JS. Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia. J Immunol 2005;175:1813-1819. (Pubitemid 41023086)
17. Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun 1998;66:912-922. (Pubitemid 28101126)
18. Khandavilli S, Homer KA, Yuste J, Basavanna S, Mitchell T, Brown JS. Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence. Mol Microbiol 2008;67:541-557.
19. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-874. (Pubitemid 40300295)
20. Davies HE, Sadler RS, Bielsa S, Maskell NA, Rahman NM, Davies RJ, Ferry BL, Lee YC. Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 2009;180:437-444.
21. Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier: molecular analysis of a novel bidirectional pathway. J Clin Invest 1998;102:347-360. (Pubitemid 28335194)
22. Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci USA 1996;93:136-140. (Pubitemid 26041483)
23. Su XY, Li GD, Liu WP, Xie B, Jiang YH. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn Cytopathol (In press)
24. Lebon A, Verkaik NJ, Labout JA, de Vogel CP, Hooijkaas H, Verbrugh HA, van Wamel WJ, Jaddoe VW, Hofman A, Hermans PW, et al. Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study. Infect Immun 2011;79:1680-1687.
25. Jaffe A, Calder AD, Owens CM, Stanojevic S, Sonnappa S. Role of routine computed tomography in paediatric pleural empyema. Thorax 2008;63:897-902.
26. Kadioglu A, Sharpe JA, Lazou I, Svanborg C, Ockleford C, Mitchell TJ, Andrew PW. Use of green fluorescent protein in visualisation of pneumococcal invasion of broncho-epithelial cells in vivo. FEMS Microbiol Lett 2001;194:105-110. (Pubitemid 32057091)
27. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M, Tuomanen E. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000;102:827-837.
28. Agarwal V, Asmat TM, Luo S, Jensch I, Zipfel PF, Hammerschmidt S. Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J BiolChem2010;285:23486-23495.
29. Cundell DR, Gerard NP, Gerard C, Idanpaan-HeikkilaI, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995;377:435-438.
30. Ahmed RA, Marrie TJ, Huang JQ. Thoracic empyema in patients with community-acquired pneumonia. Am J Med 2006;119:877-883. (Pubitemid 44415617)
31. Tarrago D, Fenoll A, Sanchez-Tatay D, Arroyo LA, Munoz-Almagro C, Esteva C, Hausdorff WP, Casal J, Obando I. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect 2008;14:828-834.
32. Fletcher M, Leeming J, Cartwright K, Finn A. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2006;25:559-560. (Pubitemid 43863370)